The Online Investor

Slideshow Mergers & Acquisitions

By The Online Investor Staff, updated Wed., Feb. 26, 1:49 PM

Slide #81. AXIM Biotechnologies, Inc. Sapphire Biotech, Inc.

Acquirer: AXIM Biotechnologies, Inc. (AXIM)
Acquiree: Sapphire Biotech, Inc.
Details: AXIM Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and cannabinoid research, announced today that its acquiree Sapphire Biotech, Inc. ("Sapphire") has signed a Sponsored Research Agreement ("SRA") with Arizona State University ("ASU") to conduct preclinical studies using Quiescin Sulfhydryl Oxidase 1 ("QSOX1") inhibitors as anti-neoplastic compounds.

  AXIM Biotechnologies, Inc.: AXIM
  Sapphire Biotech, Inc.: PRIVATE

Open the IESC Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Mergers & Acquisitions Page |

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.